GSTM1 and anemia: Whilst mortality rates in children with uncomplicated anaemia were too low either to demonstrate or refute any benefits of an immediate transfusion compared to control (WHO standard of care), the large multicentre TRACT trial demonstrated that in children with uncomplicated severe anaemia a triggered transfusion strategy was safe and cost-effective but required clinical and Hb monitoring.